OSAIC HOLDINGS, INC. - NEOLEUKIN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,245
+15.3%
1,5000.0%0.00%
Q1 2023$1,080
+8.0%
1,5000.0%0.00%
Q4 2022$1,0000.0%1,5000.0%0.00%
Q3 2022$1,000
-50.0%
1,500
-33.7%
0.00%
Q2 2022$2,000
-99.9%
2,264
+50.9%
0.00%
-100.0%
Q1 2022$3,390,000
+48328.6%
1,5000.0%0.01%
Q4 2021$7,000
-36.4%
1,5000.0%0.00%
Q3 2021$11,000
+10.0%
1,500
+50.0%
0.00%
Q2 2021$10,000
-23.1%
1,0000.0%0.00%
Q1 2021$13,000
-23.5%
1,000
-16.7%
0.00%
Q4 2020$17,0001,2000.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,047,300$5,048,0001.07%
ACT CAPITAL MANAGEMENT, LLC 212,500$1,024,0000.74%
Redmile Group, LLC 3,490,835$16,826,0000.38%
Kynam Capital Management, LP 147,000$709,0000.38%
EcoR1 Capital, LLC 860,619$4,148,0000.13%
Baker Brothers Advisors 3,821,740$18,421,0000.09%
GSA CAPITAL PARTNERS LLP 130,899$631,0000.08%
Sio Capital Management, LLC 38,312$185,0000.06%
Highland Private Wealth Management 46,999$227,0000.03%
XTX Topco Ltd 10,018$48,0000.03%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders